FOXP3 inhibits proliferation and migration by competitively inhibiting YAP1 in nasopharyngeal carcinoma
Zheng Liang(Tianjin Medical University General Hospital), Yue Shi(Shanghai Institute of Pharmaceutical Industry), Jiaxi Yu(Tianjin Medical University General Hospital), Yi Lu(Shandong Provincial Hospital), Guoguang Ying(Tianjin Medical University Cancer Institute and Hospital), Qiuping Dong(Tianjin Medical University Cancer Institute and Hospital)
Cited by 0
Related Papers
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
|JAMA Oncology|2019|1k
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study
|Therapeutic Advances in Medical Oncology|2020|110
Optimizing a 3D Culture System to Study the Interaction between Epithelial Breast Cancer and Its Surrounding Fibroblasts
|Journal of Cancer|2011|67
The microbiota-gut-brain axis and central nervous system diseases: from mechanisms of pathogenesis to therapeutic strategies
|Frontiers in Microbiology|2025|44
nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer
|Clinical Breast Cancer|2020|42